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Objective: The purpose of this study was to determine the antibacterial effect of a newly developed haemostatic 
agent Ankaferd Blood Stopper® (ABS) and Ferric Sulphate (FS) on various oral microorganisms. 
Study design: Bacterial strains were freshly incubated in their specific broth media. For each of the strains, 3 wells 
per each agent, with a 5 mm diameter were made under aseptic conditions in the specific agar media. Then they 
were filled with a test agents or 0.2% chlorhexidine digluconate (CHX) (control group). After 24h and 48h incuba-
tion periods, inhibition zones were measured. 
Results: ABS showed antibacterial effect on all test microorganisms except Lactobacillus acidophilus and Lacto-
bacillus salivarius. Ferric sulphate and CHX have antibacterial effect on all microorganisms. When the test agents 
compared, the inhibition zones of the ABS were found smaller than the ferric sulphate and CHX. 
Conclusions: Although ferric sulphate and ABS have antibacterial effect, ferric sulphate had better antibacterial 
activity than ABS on oral microorganisms under in vitro condition. FS and ABS not only exhibit the haemostatic 
activity but also antimicrobial activity. 
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Introduction
Haemorrhage control is an essential factor in dental pro-
cedure for good visualization of the fields. Dentists per-
form variety operative procedures such as pulpotomy, 
tooth extraction, biopsies, placement of endosseous im-
plants, periradicular and periodontal surgery, which may 
require haemorrage control (1, 2). The most widespread 
technique is to control bleeding by applying mechanical 
pressure to wound surface. The use of cotton balls or 
gauze pads risk leaving fibers in the surgical site. The-
se fibers may elicit a foreign body reaction and delay 
healing (3). Another technique to control bleeding is the 
application of haemostatic agents(4). Various agents are 
used for hemorrhage control in dentistry.
Ferric sulphate (Fe2[SO4]3) has been used as a coagula-
tive and haemostatic agent and it was first used in me-
dicine in 1957. On contact with blood, the agglutination 
of blood proteins result from the reaction of blood with 
ferric and sulphate ions. Thus the capillary orifices have 
been obturate by bonded proteins (3).
Medical plants have been marketed as antibacterial 
agents and haemostatic agents for many years (5, 6). 
Ankaferd Blood Stopper (ABS) (Ankaferd Sağlik Ürün-
leri A.Ş., Istanbul, Turkey) is a mixture of herbal medi-
cine and it is recently developed to facilitate the rapid 
hemorrhage control in difficult clinical conditions (6). 
ABS ingredients a standard mixture of following plants: 
Thymus vulgaris (5.0g/100ml), Glycyrrhiza glabra 
(7.0g/100ml), Vitis vinifera (8.0g/100ml), Alpinia offi-
cinarum (7.0g/100ml) and Urtica dioica (6.0g/100ml). 
ABS stimulated rapid formation of a protein network 
and erythrocyte aggregation. The ABS-induced network 
formation is related to the function of blood proteins and 
red blood cells. The basic mechanism of action for ABS 
appears to be the formation of an encapsulated protein 
network that provides focal points for erythrocyte ag-
gregation. ABS also interacts with fibrinogen and other 
blood proteins. Exposure to ABS seems to provide tis-
sue oxygenation as well as a physiological haemostatic 
process without affecting any individual clotting factor. 
This unique mechanism of action provides ABS with 
an advantage (7). ABS has been safely used in patients 
to treat epistaxis (8), after tonsillectomy (9) or variceal 
bleeding(10). In addition, ABS has been used to control 
upper gastrointestinal bleeding (11). Moreover the le-
vels of coagulation factors II, V, VIII, IX, X, XI, and XII 
were not affected by ABS; therefore, ABS might be used 
in patients with deficient primary haemostasis (12).
Many microorganism species have been detected in the 
oral cavity; some of these bacterial species can cause 
several diseases and complications. Infection of wounds 
is an important complication that impairs wound hea-
ling. A haemostatic agent should be bacteriostatic and/or 
bactericidal, when used in surgical wound. In this study, 
it was aimed to evaluate the potential antibacterial effect 
of ABS and FS under in vitro conditions.
Materials and methods
Ankaferd Blood Stopper®, ferric sulphate and 0.2% 
chlorhexidine digluconate (control group) were scree-
ned for antimicrobial activity by using well-diffusion 
technique on agar plate.
Bacterial Strain and Culture Conditions
The antibacterial activity of each material was evaluated 
against Staphylococcus aureus (S. aureus) ATCC#25923, 
methicillin sensitive S.aureus (MSSA), methicillin resis-
tant S. aureus (MRSA), Enterococcus faecalis (E.faecalis) 
(ATCC #29212), vancomycin resistant E. faecalis 
(VRE), Candida albicans (C.albicans)(ATCC#10231), 
Candida albicans oral isolate, Porphyromonas gingi-
valis (P.gingivalis) (ATCC#33277), Lactobacillus aci-
dophilus (L.acidophilus) (ATCC#4356), Lactobacillus 
salivarius (L.salivarius)(ATCC#11741), Streptococcus 
mutans (S.mutans) (ATCC#25175), Streptoccous sobri-
nus (S.sobrinus) (ATCC#33478) and Aggregatibacter 
actinomycetemcomitans (A.actinomycetemcomitans) 
(ATCC#29523).
S.mutans and S.sobrinus, were cultured in 5 ml of bra-
in heart infusion broth (BHIB, Oxoid, UK) at 37 ºC for 
48 hours in an atmosphere of 5 % CO2. E.faecalis and 
S.aureus were cultured in 5 ml of brain heart infusion 
broth (BHIB, Oxoid, UK) at 37 ºC for 48 hours aero-
bically, L.acidophilus and L.salivarius were cultured at 
37oC for 48 hours in 5 ml of MRS Broth (DeMan Rogo-
sa and Sharpe Medium, Merck, Germany) in an atmos-
phere of 10% CO2. C.albicans was cultured in autocla-
ved-sterilized Sabourraud Dextrose Broth (SDB, Oxoid, 
UK) at 37oC for 48 hours under aerobic conditions. A. 
actinomycetemcomitans and P.gingivalis were cultured 
in autoclave-sterilized trypticase soy broth (Oxoid, UK) 
supplemented sheep blood (50 ml/L), Vit K (1µg/ml) 
and hemin (5µg/ml) at 37oC for 4-5 days in an automatic 
anaerobic cabin (Electrotek AW400TG, UK) in the at-
mosphere consisted of 90% N2, 5% CO2, 5% H2. The last 
three ingredients were added to the main medium after 
filter-sterilized with 0.22µm millipore. All of the freshly 
grown bacterial suspensions in 5 ml of their specific bro-
th media as described before were adjusted to 108 cfu/
ml by using 0.5 Mc Farland test standard. For each of 
the strains, 3 wells per each agent with a 5 mm diameter 
were made under aseptic conditions in their specific agar 
media containing petri plates for each of the strains se-
parately. Then the bacterial and fungal suspensions were 
spread on to their specific agar plates. 
The wells were filled with 20μl ABS (Ankaferd® Sağlik 
Ürünleri A.Ş.) and Ferric sulhate (15.5%) (Astringe-
dent®, Ultradent Products Inc., Salt Lake City, UT, 
USA). 0.2% chlorhexidine digluconate (CHX) was se-
lected as a positive control group, because of its wides-
pread clinical use; also it serves as a common point of 
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Results 
The present study was designed to measure the direct 
inhibition of bacterial growth of 13 different bacteria. 
The inhibition degree of bacterial growth is shown in 
Table 1. All values cited are expressed as means±SD. 
Ferric sulphate and CHX showed antibacterial effect 
against all microorganisms. No bacterial inhibition was 
detected after 24 - and 48 - hour incubation with ABS 
for Lactobacillus acidophilus, Lactobacillus salivarius. 
There was no statistical significance between ABS, fer-
ric sulphate and CHX for P.gingivalis (P>0.05). CHX 
had the larger inhibition zone than ABS (p<0.05). In all 
tested microorganisms except P.gingivalis, a statistically 
significant difference was found between ABS and ferric 
sulphate (p<0.05) and, ABS showed minimum inhibiti-
on zone in 24 and 48 hours than CHX and ferric sulpha-
te. Statistical analyses of tested haemostatic agents and 
control group is shown in Table 2.
reference for comparisons with other studies (13, 14). 
Then, they were incubated on their specific media un-
der standard microbiological conditions according to the 
growth properties as described before. After 48 hours the 
inhibition zones around the wells were measured with 
a digital caliper (Mitutoyo, SP, Brazil) for P.gingivalis 
and A. actinomycetemcomitans and 24 hours for the rest 
of the others, The measurements were repeated after 48 
hours in the same manner. Tests were performed dupli-
cate for all of these agents and materials. All inhibition 
zones were measured at 24 and 48 hours by one author.
The results were statistically analyzed using One-way 
analysis of variance and Tukey’s tests for the significant 
interrelation between the groups using SPSS 13.0 for 
Windows (SPSS Inc., Chicago, IL) with the level of sta-
tistical significance set at p<0.05. 
Bacterial species
                  FeSO4 Ankaferd CHX
24h 48h 24h 48h 24h 48h
Streptococcus mutans 14.29±1.0 13.97±1.44 9.57±0.16 9.00±0.21 28.64±0.26 27.73±0.58
Streptoccous sobrinus 14.25±1.06 13.93±1.47 8.95±1.12 8.57±0.77 23.26±1.63 23.08±1.46 
Lactobacillus acidophilus 10.13±0.57 9.90±0.48 0.00±0.00 0.00±0.00 16.43±0.96 15.96±1.01 
Lactobacillus salivarius   9.35±0.56 8.90±0.21 0.00±0.00 0.00±0.00 12.70±0.77 12.42±0.45 
Staphylococcus aureus 14.53±1.08 14.37±1.23 7.46±0.28 7.25±0.79 13.24±0.68 12.60±0.70 
methisillin sensitive S.aureus 14.33±0.51 14.33±0.51 6.92±0.33 6.90±0.38 12.75±0.07 12.17±0.10 
methisillin resistant S.aureus 17.07±0.04 15.57±0.14 8.68±0.88 8.73±1.47 13.81±0.50 13.20±1.20 
Candida albicans 15.60±0.48 14.71±0.55 5.66±0.16 5.79±0.14 11.65±0.20 11.03±0.29 
C.albicans oral isolate 16.98±1.20 16.85±1.05 7.92±0.20 7.39±0.33 16.98±1.20 13.95±1.82 
Enterococcus faecalis 16.35±0.83 16.32±1.42 8.65±0.25 9.02±0.29 14.21±0.03 14.40±0.02 
vancomisin resistant E.faecalis 14.08±0.02 13.85±0.07 7.78±0.18 6.98±0.01 15.41±0.0 14.31±0.39 
Porphyromonas gingivalis 13.97±2.88 13.52±3.19 10.38±0.07 10.28±0.02 15.77±0.98 15.56±0.79 
Aggregatibacter 
actinomycetemcomitans
14.16±1.00 14.00±1.06 8.91±0.50 8.84±0.48 14.83±0.39 14.56±0.58 
Table 1. Antibacterial activity of tested haemostatic agents and control group, in millimeter inhibition (Mean ± SD) (n=3).




















                                                       P-value P-value
Streptococcus mutans .010 .000 .000 .025 .001 .001
Streptoccous sobrinus .020 .012 .003 .040 .012 .003
Lactobacillus acidophilus .001 .005 .000 .001 .005 .001
Lactobacillus salivarius .001 .019 .000 .000 .003 .000
Staphylococcus aureus .005 .326 .009 .010 .288 .022
methisillin sensitive S.aureus .001 .043 .001 .001 .021 .002
methisillin resistant S.aureus .002 .024 .007 .017 .226 .044
Candida albicans .000 .002 .001 .000 .005 .002
C.albicans oral isolate .003 .776 .003 .009 .189 .026
Enterococcus faecalis .001 .048 .003 .007 .201 .016
vancomisin resistant E.faecalis .000 .002 .000 .000 .264 .000
Porphyromonas gingivalis .250 .613 .107 .338 .589 .134
Aggregatibacter actinomycetemcomitans .010 .639 .007 .013 .754 .010
ANOVA and Tukey’s tests, significant statistically (P<0.05).
Table 2. Statistical analyses of tested haemostatic agents and control group.
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rric sulphate showed inhibition zones against all of the 
microorganisms, ABS, unfortunately, did not show any 
inhibition against both of the lactobacilli species. The-
re was no statistical significance between ABS, ferric 
sulphate and CHX for P.gingivalis (P>0.05). The zones 
of bacterial growth of ferric sulphate and CHX became 
smaller depending on time. On the other hand, the zones 
of bacterial growth of ABS for some microorganisms 
became larger depending on time. However, these di-
fferences at 24- and 48- hour incubation for all tested 
materials and control group were insignificant to make 
inferences.
The effectiveness of ABS was due to the antimicrobial 
effect of several contents. Fukai et al. (19) stated that 
Glycyrrhiza glabra have antimicrobial activity against 
S.aureus, MSSA and MRSA. Lee et al. (20) explain that 
Alpinia officinarum has been used in Korea for several 
hundred years to treat various infectious diseases. Agni-
hotri and Vaidya(21) showed Thymus vulgaris has had 
antibacterial effect. Similar to our findings, Tasdelen-
Fisgin et al.(6) reported that ABS has antibacterial ac-
tivity against methicillin resistant S.aureus (MRSA), 
methicillin sensitive S.aureus (MSSA), and vancomycin 
resistant E. faecalis (VRE).
Conclusions
In summary, a haemostatic agent should be bacterios-
tatic and/or bactericidal, when used in surgical wound. 
Based on the result of this study, FS had better antibac-
terial activity than ABS under in vitro conditions. The 
results of this study provide the information that FS and 
ABS not only exhibit the haemostatic activity but also 
antimicrobial activity. This may be an important finding 
in terms of wound healing. 
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